cancer immunotherapy

You have access
Cytokine-based Cancer Immunotherapy: Challenges and Opportunities for IL-10
KATHRINE S. RALLIS, AMBER E. CORRIGAN, HASHIM DADAH, ALAN MATHEW GEORGE, SUMIRAT M. KESHWARA, MICHAIL SIDERIS and BERNADETT SZABADOS

Anticancer Research July 2021, 41 (7) 3247-3252; DOI: https://doi.org/10.21873/anticanres.15110
You have access
T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)
KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES

Anticancer Research March 2021, 41 (3) 1123-1141; DOI: https://doi.org/10.21873/anticanres.14870
You have access
T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell Therapies
KATHRINE S. RALLIS, CHRISTOPHER R.T. HILLYAR, MICHAIL SIDERIS and JEFF K. DAVIES

Anticancer Research March 2021, 41 (3) 1143-1156; DOI: https://doi.org/10.21873/anticanres.14871
You have access
Therapeutic Time-restricted Feeding Reduces Renal Tumor Bioluminescence in Mice but Fails to Improve Anti-CTLA-4 Efficacy
WILLIAM J. TURBITT, RACHAEL M. ORLANDELLA, JUSTIN T. GIBSON, COURTNEY M. PETERSON and LYSE A. NORIAN

Anticancer Research October 2020, 40 (10) 5445-5456; DOI: https://doi.org/10.21873/anticanres.14555
You have access
Expression of Immune Checkpoint Receptors on T-Cells and Their Ligands on Leukemia Blasts in Childhood Acute Leukemia
SUNG HAN KANG, HYUN JU HWANG, JAE WON YOO, HYERY KIM, EUN SEOK CHOI, SANG-HYUN HWANG, YOUNG-UK CHO, SEONGSOO JANG, CHAN-JEOUNG PARK, HO JOON IM, JONG JIN SEO, NAYOUNG KIM and KYUNG-NAM KOH

Anticancer Research October 2019, 39 (10) 5531-5539; DOI: https://doi.org/10.21873/anticanres.13746
You have access
Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model
RACHEL A. CROSSLEY, ALYSSA MATZ, TERRY DEW, ASHLEY KALINAUSKAS, NICOLE FAUCETTE, BRAD POFF, LAWRENCE K. SILBART and MARK A. SUCKOW

Anticancer Research April 2019, 39 (4) 1699-1703; DOI: https://doi.org/10.21873/anticanres.13275
You have access
Mismatch Repair Protein Deficiency Is a Risk Factor for Aberrant Expression of HLA Class I Molecules: A Putative “Adaptive Immune Escape” Phenomenon
TERUFUMI KUBO, YOSHIHIKO HIROHASHI, KAZUHIKO MATSUO, TOMOKO SONODA, HIROKI SAKAMOTO, KIYOSHI FURUMURA, TOMOHIDE TSUKAHARA, TAKAYUKI KANASEKI, MUNEHIDE NAKATSUGAWA, HIROSHI HIRANO, TOMOHISA FURUHATA, ICHIRO TAKEMASA, TADASHI HASEGAWA and TOSHIHIKO TORIGOE

Anticancer Research March 2017, 37 (3) 1289-1295;
You have access
Sugar-carrying Polystyrenes Facilitate Harvesting of APCs from MLRs: Possible Application of Sugar-carrying Polystyrenes to Immunotherapy
AKIRA IMAIZUMI, HIDEYA ONISHI, AKIO YAMASAKI, MAKOTO KAWAMOTO, TAKASHI MORISAKI, MITSUAKI GOTO, MASAMICHI IWAMA, TOSHIHIRO AKAIKE and KENICHIRO HASUMI

Anticancer Research February 2016, 36 (2) 673-676;
You have access
Combination Immunotherapy with 4-1BB Activation and PD-1 Blockade Enhances Antitumor Efficacy in a Mouse Model of Subcutaneous Tumor
YOSHITARO SHINDO, KIYOSHI YOSHIMURA, ATSUO KURAMASU, YUSAKU WATANABE, HIDEAKI ITO, TOMOKO KONDO, ATSUNORI OGA, HIROSHI ITO, SHIGEFUMI YOSHINO, SHOICHI HAZAMA, KOJI TAMADA, HIDEO YAGITA and MASAAKI OKA

Anticancer Research January 2015, 35 (1) 129-136;
You have access
Recognition of a Natural WT1 Epitope by a Modified WT1 Peptide-specific T-Cell Receptor
TAICHI TAMANAKA, YOSHIHIRO OKA, FUMIHIRO FUJIKI, AKIHIRO TSUBOI, AKIKO KATSUHARA, HIROKO NAKAJIMA, NAOKI HOSEN, SUMIYUKI NISHIDA, YU-HUNG LIN, SHO TACHINO, YOSHIKI AKATSUKA, KIYOTAKA KUZUSHIMA, YUSUKE OJI, ATSUSHI KUMANOGOH and HARUO SUGIYAMA

Anticancer Research December 2012, 32 (12) 5201-5209;

Main menu

User menu

Search

cancer immunotherapy